Pelvic radiation test for uterine or cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies a specific radiation schedule aimed at the pelvis (lower belly area) for uterine or cervical cancer. It looks at whether this “hypofractionated” approach can control cancer while limiting side effects, especially in patients whose disease has not spread to distant organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have uterine (endometrial) cancer or cervical cancer.
- Your cancer has not spread to distant organs (non-metastatic).
- After surgery, there is no visible remaining cancer based on imaging and your surgeon’s findings.
- You plan to receive whole-pelvis radiation; it should not include chemo at the same time (chemo before or after is sometimes okay).
- You are well enough for treatment (ECOG performance status 2 or less).
- You have not had prior radiation to the pelvis and you do not have bowel conditions that commonly flare (like inflammatory bowel disease or bowel blockage history).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, focused radiation treatment to the pelvis after surgery for cervical or uterine cancer. It aims to reduce the chance of cancer coming back in patients whose doctors recommend additional radiation therapy after their surgery.
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
This trial tests whether using MRI scans daily during pelvic radiation therapy improves treatment precision and outcomes for endometrial cancer patients who need radiation after surgery. The goal is to better target cancer while reducing side effects.
This trial studies a shorter, focused radiation schedule given after surgery for certain higher-risk cervical or endometrial (uterine) cancers. It may help reduce cancer recurrence while checking side effects in the bladder and bowel area.
This trial tests a shorter, more targeted type of radiation therapy for people with endometrial or cervical cancer who have had surgery. It aims to reduce side effects by using daily scans to adjust the treatment plan.
This trial studies giving radiation after surgery for certain early-stage uterine (endometrial) cancer types. It may help lower the chance the cancer comes back, especially for higher-grade cases.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.